Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.
Nhu LNT. et al, (2024), Wellcome open research, 9
Early transcriptional responses to human enteric fever challenge.
Barton A. et al, (2023), Infect Immun
Molecular correlates of vaccine-induced protection against typhoid fever.
Zhu H. et al, (2023), J Clin Invest
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
McCann N. et al, (2023), BMJ Open, 13
A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus.
Inthawong M. et al, (2023), PLoS Negl Trop Dis, 17
A tool for evaluating heterogeneity in avidity of polyclonal antibodies.
Li K. et al, (2023), Front Immunol, 14
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children
Stockdale L. et al, (2022), Frontiers in Analytical Science, 2
Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.
Barton A. et al, (2022), Infect Immun, 90
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Tomic A. et al, (2022), Nat Commun, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
Shakya M. et al, (2021), Lancet Glob Health, 9, e1561 - e1568
Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.
Dahora LC. et al, (2021), Sci Immunol, 6
Persistence of Antibody After a Vi-Tetanus Toxoid Conjugate Vaccine and Effect of Boosting With a Plain Polysaccharide Vaccine on Vi Antibody and Antigen-Specific B Cells
Bentley T. et al, (2021), Frontiers in Tropical Diseases, 2
Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination
Johnson M. et al, (2021), Frontiers in Tropical Diseases, 2
Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella.
J Barton A. et al, (2021), FEMS Microbiol Rev, 45
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly DT. et al, (2021), Nat Commun, 12
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Barrett JR. et al, (2021), Nat Med, 27